Literature DB >> 22866979

Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy.

David W Piotrowski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22866979     DOI： 10.1021/jm300806c

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists.

Authors:  Christine Yang; Jaume Balsells; Hong D Chu; Jason M Cox; Alejandro Crespo; Xiuying Ma; Lisa Contino; Patricia Brown; Sheng Gao; Beata Zamlynny; Judyann Wiltsie; Joseph Clemas; JeanMarie Lisnock; Jack Gibson; Gaochao Zhou; Margarita Garcia-Calvo; Thomas J Bateman; Vincent Tong; Ling Xu; Martin Crook; Peter Sinclair; Hong C Shen
Journal:  ACS Med Chem Lett       Date:  2015-03-06       Impact factor: 4.345

2.  Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods.

Authors:  Katarina Roos; Anders Hogner; Derek Ogg; Martin J Packer; Eva Hansson; Kenneth L Granberg; Emma Evertsson; Anneli Nordqvist
Journal:  J Comput Aided Mol Des       Date:  2015-11-16       Impact factor: 3.686

3.  Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.

Authors:  Ning Yan; Li Wen; Rui Peng; Hongmei Li; Handeng Liu; Huimin Peng; Yan Sun; Tianhui Wu; Lei Chen; Qingrui Duan; Yixuan Sun; Qin Zhou; Lijiang Wei; Zheng Zhang
Journal:  J Diabetes Res       Date:  2016-06-30       Impact factor: 4.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.